Surveillance of AMR in DRC

NCT06821282 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 210

Last updated 2025-02-20

No results posted yet for this study

Summary

This study addresses knowledge gaps regarding antimicrobial resistance (AMR) in sub-Saharan Africa, focusing on evaluating the feasibility of AMR surveillance and enhancing local research capacity. Conducted at a general referral hospital in semirural Kinshasa, DRC, the study will investigate bacterial infections, their resistance profiles, and related risk factors, including co-infections such as malaria.

Conditions

  • Bacteremia

Sponsors & Collaborators

  • University of Kinshasa

    collaborator OTHER
  • Mahidol University

    collaborator OTHER
  • Institut National de Recherche Biomédicale (INRB). Kinshasa, Democratic Republic of Congo

    collaborator UNKNOWN
  • Department of Infectious Diseases, The Alfred Hospital and School of Translational Medicine, Monash University, Melbourne, Australia

    collaborator UNKNOWN
  • University of Oxford

    lead OTHER

Principal Investigators

  • Caterina Fanello, Dr. · Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, United Kingdom (UK)

  • Sue J Lee, Dr. · Mahidol-Oxford Research Unit (MORU), Faculty of Tropical Medicine, Mahidol University, Bangkok,Thailand

Eligibility

Min Age
6 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-11
Primary Completion
2025-03-30
Completion
2025-09-30

Countries

  • Democratic Republic of the Congo

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06821282 on ClinicalTrials.gov